Literature DB >> 18509673

Granulomatous hepatitis, perihepatic lymphadenopathies, and autoantibody positivity: an unusual association in a child with hepatitis C.

Odul Egritas1, Sinan Sari, Buket Dalgic, Cigdem Vural, Gulen Akyol.   

Abstract

A 10-year-old boy with hepatitis C had granulomatous hepatitis (GH) at initial liver biopsy. He also had enlarged perihepatic lymph nodes and smooth muscle antibody (SMA) positivity. GH is a rare finding in hepatitis C virus (HCV) infection. Our patient is special since GH secondary to HCV infection was associated with both autoantibodies and multiple intraabdominal lymphadenopathies. After interferon (IFN) and ribavirin therapy, HCV RNA became negative, along with the resolution of hepatic granulomas (HG), lymphadenopathies, and SMA positivity. Although early virologic response was not achieved under IFN treatment, the therapy period was extended, contrary to routine practice, and resulted in a delayed response. We conclude that the usage of IFN for longer periods in GH-associated HCV infection might be promising.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18509673     DOI: 10.1007/s00431-008-0749-3

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  20 in total

1.  Virus, liver and autoimmunity.

Authors:  D P Bogdanos; G Mieli-Vergani; D Vergani
Journal:  Dig Liver Dis       Date:  2000 Jun-Jul       Impact factor: 4.088

2.  Identification of a new autoantibody in patients with chronic hepatitis.

Authors:  Yasunobu Fukuda; Hiroshi Yotsuyanagi; Seido Ooka; Taichi Sekine; Junki Koike; Toshifumi Takano; Michihiro Suzuki; Fumio Itoh; Kusuki Nishioka; Tomohiro Kato
Journal:  Hum Immunol       Date:  2004-12       Impact factor: 2.850

3.  Granulomas and hepatitis C.

Authors:  R D Goldin; T S Levine; G R Foster; H C Thomas
Journal:  Histopathology       Date:  1996-03       Impact factor: 5.087

4.  Meeting report: International Autoimmune Hepatitis Group.

Authors:  P J Johnson; I G McFarlane
Journal:  Hepatology       Date:  1993-10       Impact factor: 17.425

5.  Autoantibody in a patient with chronic hepatitis C virus infection showing complete remission after interferon therapy.

Authors:  Yoshihiro Akashi; Masayuki Inoh; Kunio Seto; Naoyuki Gamo; Makoto Kuboki; Noriyuki Kurata
Journal:  J Gastroenterol Hepatol       Date:  2002-08       Impact factor: 4.029

6.  Binding of hepatitis C virus to CD81.

Authors:  P Pileri; Y Uematsu; S Campagnoli; G Galli; F Falugi; R Petracca; A J Weiner; M Houghton; D Rosa; G Grandi; S Abrignani
Journal:  Science       Date:  1998-10-30       Impact factor: 47.728

7.  The prevalence of hepatic granulomas in chronic hepatitis C.

Authors:  Resat Ozaras; Veysel Tahan; Ali Mert; Suleyman Uraz; Mustafa Kanat; Fehmi Tabak; Erol Avsar; Gulsen Ozbay; Cigdem Ataizi Celikel; Nurdan Tozun; Hakan Senturk
Journal:  J Clin Gastroenterol       Date:  2004 May-Jun       Impact factor: 3.062

8.  Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population.

Authors:  P Muratori; L Muratori; T Stroffolini; G Pappas; P Terlizzi; R Ferrari; S Loffreda; F Cassani; M Rapicetta; V Guadagnino; F B Bianchi; M Lenzi
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

9.  Epithelioid cell granulomas in chronic hepatitis C: immunohistochemical character and histological marker of favourable response to interferon-alpha therapy.

Authors:  K Harada; H Minato; K Hiramatsu; Y Nakanuma
Journal:  Histopathology       Date:  1998-09       Impact factor: 5.087

10.  The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C.

Authors:  Hermann E Wasmuth; Christian Stolte; Andreas Geier; Christoph G Dietrich; Carsten Gartung; Johann Lorenzen; Siegfried Matern; Frank Lammert
Journal:  BMC Infect Dis       Date:  2004-02-13       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.